Avanos Medical (AVNS) Projected to Post Earnings on Wednesday

Avanos Medical (NYSE:AVNS) is anticipated to release its earnings data before the market opens on Wednesday, February 26th. Analysts expect Avanos Medical to post earnings of $0.40 per share and revenue of $177.23 million for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Avanos Medical Trading Up 1.3 %

Shares of Avanos Medical stock opened at $15.65 on Tuesday. The firm has a market capitalization of $719.37 million, a PE ratio of 46.04 and a beta of 0.98. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12. The firm’s 50 day moving average is $16.18 and its 200 day moving average is $19.78. Avanos Medical has a 1 year low of $14.98 and a 1 year high of $25.36.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.